Neurolymphomatosis is a rare clinical entity and has mainly been described as primary lymphomatous infiltration of the nerves and as a relapse or progression of disease after previous treatments. In this case report, we describe an unusual occurrence of neurolymphomatosis evolving in mid-cycle chemotherapy.
This article is available only as a PDF. Please click on “Download PDF” on top to view the full article.
